House Republicans to probe FDA's delayed decision on decongestants

Oral decongestants with phenylephrine in the U.S. generated almost $1.8 billion in sales last year, FDA data shows.

Related Keywords

United States ,Americans ,American ,Lisa Mcclain ,Vicks Dayquil ,Johnson ,House Subcommittee On Health Care ,Drug Administration ,Financial Services ,House Republicans ,House Subcommittee ,Health Care ,Robert Califf ,Chairwoman Lisa Mcclain ,